 | • レポートコード：MRC2-11QY10699 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は組織プラスミノーゲン活性化因子のグローバル市場について調査・分析したレポートです。種類別（活性tPA、阻害剤タイプ1（PAI-1）・複合体形成tPA、C1阻害剤・複合体形成tPA）市場規模、用途別（虚血性脳卒中、肺塞栓症、心筋梗塞、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別組織プラスミノーゲン活性化因子の競争状況、市場シェア ・世界の組織プラスミノーゲン活性化因子市場：種類別市場規模 2015年-2020年（活性tPA、阻害剤タイプ1（PAI-1）・複合体形成tPA、C1阻害剤・複合体形成tPA） ・世界の組織プラスミノーゲン活性化因子市場：種類別市場規模予測 2021年-2026年（活性tPA、阻害剤タイプ1（PAI-1）・複合体形成tPA、C1阻害剤・複合体形成tPA） ・世界の組織プラスミノーゲン活性化因子市場：用途別市場規模 2015年-2020年（虚血性脳卒中、肺塞栓症、心筋梗塞、その他） ・世界の組織プラスミノーゲン活性化因子市場：用途別市場規模予測 2021年-2026年（虚血性脳卒中、肺塞栓症、心筋梗塞、その他） ・北米の組織プラスミノーゲン活性化因子市場分析：米国、カナダ ・ヨーロッパの組織プラスミノーゲン活性化因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの組織プラスミノーゲン活性化因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の組織プラスミノーゲン活性化因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの組織プラスミノーゲン活性化因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Genentech、Sigma-Aldrich、Taj Pharmaceuticals、Zydus Cadila Healthcare、Calbiochem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tissue plasminogen activator (abbreviated tPA or PLAT) is a protein involved in the breakdown of blood clots. It is a serine protease found on endothelial cells, the cells that line the blood vessels. As an enzyme, it catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. Human tPA has a molecular weight of ~70 kDa in the single-chain form.
Market Analysis and Insights: Global Tissue Plasminogen Activator Market
The global Tissue Plasminogen Activator market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tissue Plasminogen Activator Scope and Market Size
Tissue Plasminogen Activator market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tissue Plasminogen Activator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tissue Plasminogen Activator market is segmented into
Active tPA
tPA Complexed with Inhibitor Type 1 (PAI-1)
tPA Complexed with C1-inhibitor
Segment by Application, the Tissue Plasminogen Activator market is segmented into
Ischemic Stroke
Pulmonary Embolism
Myocardial Infarction
Others
Regional and Country-level Analysis
The Tissue Plasminogen Activator market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tissue Plasminogen Activator market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tissue Plasminogen Activator Market Share Analysis
Tissue Plasminogen Activator market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tissue Plasminogen Activator business, the date to enter into the Tissue Plasminogen Activator market, Tissue Plasminogen Activator product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Genentech
Sigma-Aldrich
Taj Pharmaceuticals
Zydus Cadila Healthcare
Calbiochem
…
1 Study Coverage
1.1 Tissue Plasminogen Activator Product Introduction
1.2 Market Segments
1.3 Key Tissue Plasminogen Activator Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tissue Plasminogen Activator Market Size Growth Rate by Type
1.4.2 Active tPA
1.4.3 tPA Complexed with Inhibitor Type 1 (PAI-1)
1.4.4 tPA Complexed with C1-inhibitor
1.5 Market by Application
1.5.1 Global Tissue Plasminogen Activator Market Size Growth Rate by Application
1.5.2 Ischemic Stroke
1.5.3 Pulmonary Embolism
1.5.4 Myocardial Infarction
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tissue Plasminogen Activator Market Size, Estimates and Forecasts
2.1.1 Global Tissue Plasminogen Activator Revenue 2015-2026
2.1.2 Global Tissue Plasminogen Activator Sales 2015-2026
2.2 Global Tissue Plasminogen Activator, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tissue Plasminogen Activator Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tissue Plasminogen Activator Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tissue Plasminogen Activator Competitor Landscape by Players
3.1 Tissue Plasminogen Activator Sales by Manufacturers
3.1.1 Tissue Plasminogen Activator Sales by Manufacturers (2015-2020)
3.1.2 Tissue Plasminogen Activator Sales Market Share by Manufacturers (2015-2020)
3.2 Tissue Plasminogen Activator Revenue by Manufacturers
3.2.1 Tissue Plasminogen Activator Revenue by Manufacturers (2015-2020)
3.2.2 Tissue Plasminogen Activator Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tissue Plasminogen Activator Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tissue Plasminogen Activator Revenue in 2019
3.2.5 Global Tissue Plasminogen Activator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tissue Plasminogen Activator Price by Manufacturers
3.4 Tissue Plasminogen Activator Manufacturing Base Distribution, Product Types
3.4.1 Tissue Plasminogen Activator Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tissue Plasminogen Activator Product Type
3.4.3 Date of International Manufacturers Enter into Tissue Plasminogen Activator Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tissue Plasminogen Activator Market Size by Type (2015-2020)
4.1.1 Global Tissue Plasminogen Activator Sales by Type (2015-2020)
4.1.2 Global Tissue Plasminogen Activator Revenue by Type (2015-2020)
4.1.3 Tissue Plasminogen Activator Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tissue Plasminogen Activator Market Size Forecast by Type (2021-2026)
4.2.1 Global Tissue Plasminogen Activator Sales Forecast by Type (2021-2026)
4.2.2 Global Tissue Plasminogen Activator Revenue Forecast by Type (2021-2026)
4.2.3 Tissue Plasminogen Activator Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tissue Plasminogen Activator Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tissue Plasminogen Activator Market Size by Application (2015-2020)
5.1.1 Global Tissue Plasminogen Activator Sales by Application (2015-2020)
5.1.2 Global Tissue Plasminogen Activator Revenue by Application (2015-2020)
5.1.3 Tissue Plasminogen Activator Price by Application (2015-2020)
5.2 Tissue Plasminogen Activator Market Size Forecast by Application (2021-2026)
5.2.1 Global Tissue Plasminogen Activator Sales Forecast by Application (2021-2026)
5.2.2 Global Tissue Plasminogen Activator Revenue Forecast by Application (2021-2026)
5.2.3 Global Tissue Plasminogen Activator Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tissue Plasminogen Activator by Country
6.1.1 North America Tissue Plasminogen Activator Sales by Country
6.1.2 North America Tissue Plasminogen Activator Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tissue Plasminogen Activator Market Facts & Figures by Type
6.3 North America Tissue Plasminogen Activator Market Facts & Figures by Application
7 Europe
7.1 Europe Tissue Plasminogen Activator by Country
7.1.1 Europe Tissue Plasminogen Activator Sales by Country
7.1.2 Europe Tissue Plasminogen Activator Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tissue Plasminogen Activator Market Facts & Figures by Type
7.3 Europe Tissue Plasminogen Activator Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tissue Plasminogen Activator by Region
8.1.1 Asia Pacific Tissue Plasminogen Activator Sales by Region
8.1.2 Asia Pacific Tissue Plasminogen Activator Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tissue Plasminogen Activator Market Facts & Figures by Type
8.3 Asia Pacific Tissue Plasminogen Activator Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tissue Plasminogen Activator by Country
9.1.1 Latin America Tissue Plasminogen Activator Sales by Country
9.1.2 Latin America Tissue Plasminogen Activator Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tissue Plasminogen Activator Market Facts & Figures by Type
9.3 Central & South America Tissue Plasminogen Activator Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tissue Plasminogen Activator by Country
10.1.1 Middle East and Africa Tissue Plasminogen Activator Sales by Country
10.1.2 Middle East and Africa Tissue Plasminogen Activator Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tissue Plasminogen Activator Market Facts & Figures by Type
10.3 Middle East and Africa Tissue Plasminogen Activator Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Tissue Plasminogen Activator Products Offered
11.1.5 Bayer AG Related Developments
11.2 Genentech
11.2.1 Genentech Corporation Information
11.2.2 Genentech Description and Business Overview
11.2.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Genentech Tissue Plasminogen Activator Products Offered
11.2.5 Genentech Related Developments
11.3 Sigma-Aldrich
11.3.1 Sigma-Aldrich Corporation Information
11.3.2 Sigma-Aldrich Description and Business Overview
11.3.3 Sigma-Aldrich Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sigma-Aldrich Tissue Plasminogen Activator Products Offered
11.3.5 Sigma-Aldrich Related Developments
11.4 Taj Pharmaceuticals
11.4.1 Taj Pharmaceuticals Corporation Information
11.4.2 Taj Pharmaceuticals Description and Business Overview
11.4.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Taj Pharmaceuticals Tissue Plasminogen Activator Products Offered
11.4.5 Taj Pharmaceuticals Related Developments
11.5 Zydus Cadila Healthcare
11.5.1 Zydus Cadila Healthcare Corporation Information
11.5.2 Zydus Cadila Healthcare Description and Business Overview
11.5.3 Zydus Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Zydus Cadila Healthcare Tissue Plasminogen Activator Products Offered
11.5.5 Zydus Cadila Healthcare Related Developments
11.6 Calbiochem
11.6.1 Calbiochem Corporation Information
11.6.2 Calbiochem Description and Business Overview
11.6.3 Calbiochem Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Calbiochem Tissue Plasminogen Activator Products Offered
11.6.5 Calbiochem Related Developments
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Tissue Plasminogen Activator Products Offered
11.1.5 Bayer AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tissue Plasminogen Activator Market Estimates and Projections by Region
12.1.1 Global Tissue Plasminogen Activator Sales Forecast by Regions 2021-2026
12.1.2 Global Tissue Plasminogen Activator Revenue Forecast by Regions 2021-2026
12.2 North America Tissue Plasminogen Activator Market Size Forecast (2021-2026)
12.2.1 North America: Tissue Plasminogen Activator Sales Forecast (2021-2026)
12.2.2 North America: Tissue Plasminogen Activator Revenue Forecast (2021-2026)
12.2.3 North America: Tissue Plasminogen Activator Market Size Forecast by Country (2021-2026)
12.3 Europe Tissue Plasminogen Activator Market Size Forecast (2021-2026)
12.3.1 Europe: Tissue Plasminogen Activator Sales Forecast (2021-2026)
12.3.2 Europe: Tissue Plasminogen Activator Revenue Forecast (2021-2026)
12.3.3 Europe: Tissue Plasminogen Activator Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tissue Plasminogen Activator Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tissue Plasminogen Activator Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tissue Plasminogen Activator Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tissue Plasminogen Activator Market Size Forecast by Region (2021-2026)
12.5 Latin America Tissue Plasminogen Activator Market Size Forecast (2021-2026)
12.5.1 Latin America: Tissue Plasminogen Activator Sales Forecast (2021-2026)
12.5.2 Latin America: Tissue Plasminogen Activator Revenue Forecast (2021-2026)
12.5.3 Latin America: Tissue Plasminogen Activator Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tissue Plasminogen Activator Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tissue Plasminogen Activator Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tissue Plasminogen Activator Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tissue Plasminogen Activator Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tissue Plasminogen Activator Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tissue Plasminogen Activator Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tissue Plasminogen Activator Market Segments
Table 2. Ranking of Global Top Tissue Plasminogen Activator Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tissue Plasminogen Activator Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Active tPA
Table 5. Major Manufacturers of tPA Complexed with Inhibitor Type 1 (PAI-1)
Table 6. Major Manufacturers of tPA Complexed with C1-inhibitor
Table 7. Global Tissue Plasminogen Activator Market Size Growth Rate by Application 2020-2026 (MT)
Table 8. Global Tissue Plasminogen Activator Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 9. Global Tissue Plasminogen Activator Sales by Regions 2015-2020 (MT)
Table 10. Global Tissue Plasminogen Activator Sales Market Share by Regions (2015-2020)
Table 11. Global Tissue Plasminogen Activator Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Tissue Plasminogen Activator Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Tissue Plasminogen Activator Sales Share by Manufacturers (2015-2020)
Table 14. Global Tissue Plasminogen Activator Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Tissue Plasminogen Activator by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tissue Plasminogen Activator as of 2019)
Table 16. Tissue Plasminogen Activator Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Tissue Plasminogen Activator Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Tissue Plasminogen Activator Price (2015-2020) (USD/MT)
Table 19. Tissue Plasminogen Activator Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Tissue Plasminogen Activator Product Type
Table 21. Date of International Manufacturers Enter into Tissue Plasminogen Activator Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 24. Global Tissue Plasminogen Activator Sales Share by Type (2015-2020)
Table 25. Global Tissue Plasminogen Activator Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Tissue Plasminogen Activator Revenue Share by Type (2015-2020)
Table 27. Tissue Plasminogen Activator Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 29. Global Tissue Plasminogen Activator Sales Share by Application (2015-2020)
Table 30. North America Tissue Plasminogen Activator Sales by Country (2015-2020) (MT)
Table 31. North America Tissue Plasminogen Activator Sales Market Share by Country (2015-2020)
Table 32. North America Tissue Plasminogen Activator Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Tissue Plasminogen Activator Revenue Market Share by Country (2015-2020)
Table 34. North America Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 35. North America Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Table 36. North America Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 37. North America Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Table 38. Europe Tissue Plasminogen Activator Sales by Country (2015-2020) (MT)
Table 39. Europe Tissue Plasminogen Activator Sales Market Share by Country (2015-2020)
Table 40. Europe Tissue Plasminogen Activator Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Tissue Plasminogen Activator Revenue Market Share by Country (2015-2020)
Table 42. Europe Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 43. Europe Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Table 44. Europe Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 45. Europe Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Tissue Plasminogen Activator Sales by Region (2015-2020) (MT)
Table 47. Asia Pacific Tissue Plasminogen Activator Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Tissue Plasminogen Activator Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Tissue Plasminogen Activator Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 51. Asia Pacific Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 53. Asia Pacific Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Table 54. Latin America Tissue Plasminogen Activator Sales by Country (2015-2020) (MT)
Table 55. Latin America Tissue Plasminogen Activator Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Tissue Plasminogen Activator Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Tissue Plasminogen Activator Revenue Market Share by Country (2015-2020)
Table 58. Latin America Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 59. Latin America Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Table 60. Latin America Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 61. Latin America Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Tissue Plasminogen Activator Sales by Country (2015-2020) (MT)
Table 63. Middle East and Africa Tissue Plasminogen Activator Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Tissue Plasminogen Activator Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Tissue Plasminogen Activator Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Tissue Plasminogen Activator Sales by Type (2015-2020) (MT)
Table 67. Middle East and Africa Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Tissue Plasminogen Activator Sales by Application (2015-2020) (MT)
Table 69. Middle East and Africa Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Table 70. Bayer AG Corporation Information
Table 71. Bayer AG Description and Major Businesses
Table 72. Bayer AG Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Bayer AG Product
Table 74. Bayer AG Recent Development
Table 75. Genentech Corporation Information
Table 76. Genentech Description and Major Businesses
Table 77. Genentech Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Genentech Product
Table 79. Genentech Recent Development
Table 80. Sigma-Aldrich Corporation Information
Table 81. Sigma-Aldrich Description and Major Businesses
Table 82. Sigma-Aldrich Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sigma-Aldrich Product
Table 84. Sigma-Aldrich Recent Development
Table 85. Taj Pharmaceuticals Corporation Information
Table 86. Taj Pharmaceuticals Description and Major Businesses
Table 87. Taj Pharmaceuticals Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Taj Pharmaceuticals Product
Table 89. Taj Pharmaceuticals Recent Development
Table 90. Zydus Cadila Healthcare Corporation Information
Table 91. Zydus Cadila Healthcare Description and Major Businesses
Table 92. Zydus Cadila Healthcare Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Zydus Cadila Healthcare Product
Table 94. Zydus Cadila Healthcare Recent Development
Table 95. Calbiochem Corporation Information
Table 96. Calbiochem Description and Major Businesses
Table 97. Calbiochem Tissue Plasminogen Activator Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Calbiochem Product
Table 99. Calbiochem Recent Development
Table 100. Global Tissue Plasminogen Activator Sales Forecast by Regions (2021-2026) (MT)
Table 101. Global Tissue Plasminogen Activator Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Tissue Plasminogen Activator Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Tissue Plasminogen Activator Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Tissue Plasminogen Activator Sales Forecast by Country (2021-2026) (MT)
Table 105. North America: Tissue Plasminogen Activator Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Tissue Plasminogen Activator Sales Forecast by Country (2021-2026) (MT)
Table 107. Europe: Tissue Plasminogen Activator Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Tissue Plasminogen Activator Sales Forecast by Region (2021-2026) (MT)
Table 109. Asia Pacific: Tissue Plasminogen Activator Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Tissue Plasminogen Activator Sales Forecast by Country (2021-2026) (MT)
Table 111. Latin America: Tissue Plasminogen Activator Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Tissue Plasminogen Activator Sales Forecast by Country (2021-2026) (MT)
Table 113. Middle East and Africa: Tissue Plasminogen Activator Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Tissue Plasminogen Activator Players
Table 118. Tissue Plasminogen Activator Customers List
Table 119. Tissue Plasminogen Activator Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Tissue Plasminogen Activator Product Picture
Figure 2. Global Tissue Plasminogen Activator Sales Market Share by Type in 2020 & 2026
Figure 3. Active tPA Product Picture
Figure 4. tPA Complexed with Inhibitor Type 1 (PAI-1) Product Picture
Figure 5. tPA Complexed with C1-inhibitor Product Picture
Figure 6. Global Tissue Plasminogen Activator Sales Market Share by Application in 2020 & 2026
Figure 7. Ischemic Stroke
Figure 8. Pulmonary Embolism
Figure 9. Myocardial Infarction
Figure 10. Others
Figure 11. Tissue Plasminogen Activator Report Years Considered
Figure 12. Global Tissue Plasminogen Activator Market Size 2015-2026 (US$ Million)
Figure 13. Global Tissue Plasminogen Activator Sales 2015-2026 (MT)
Figure 14. Global Tissue Plasminogen Activator Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Tissue Plasminogen Activator Sales Market Share by Region (2015-2020)
Figure 16. Global Tissue Plasminogen Activator Sales Market Share by Region in 2019
Figure 17. Global Tissue Plasminogen Activator Revenue Market Share by Region (2015-2020)
Figure 18. Global Tissue Plasminogen Activator Revenue Market Share by Region in 2019
Figure 19. Global Tissue Plasminogen Activator Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Tissue Plasminogen Activator Revenue in 2019
Figure 21. Tissue Plasminogen Activator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Tissue Plasminogen Activator Sales Market Share by Type (2015-2020)
Figure 23. Global Tissue Plasminogen Activator Sales Market Share by Type in 2019
Figure 24. Global Tissue Plasminogen Activator Revenue Market Share by Type (2015-2020)
Figure 25. Global Tissue Plasminogen Activator Revenue Market Share by Type in 2019
Figure 26. Global Tissue Plasminogen Activator Market Share by Price Range (2015-2020)
Figure 27. Global Tissue Plasminogen Activator Sales Market Share by Application (2015-2020)
Figure 28. Global Tissue Plasminogen Activator Sales Market Share by Application in 2019
Figure 29. Global Tissue Plasminogen Activator Revenue Market Share by Application (2015-2020)
Figure 30. Global Tissue Plasminogen Activator Revenue Market Share by Application in 2019
Figure 31. North America Tissue Plasminogen Activator Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Tissue Plasminogen Activator Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Tissue Plasminogen Activator Sales Market Share by Country in 2019
Figure 34. North America Tissue Plasminogen Activator Revenue Market Share by Country in 2019
Figure 35. U.S. Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Tissue Plasminogen Activator Market Share by Type in 2019
Figure 40. North America Tissue Plasminogen Activator Market Share by Application in 2019
Figure 41. Europe Tissue Plasminogen Activator Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Tissue Plasminogen Activator Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Tissue Plasminogen Activator Sales Market Share by Country in 2019
Figure 44. Europe Tissue Plasminogen Activator Revenue Market Share by Country in 2019
Figure 45. Germany Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 48. France Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Tissue Plasminogen Activator Market Share by Type in 2019
Figure 56. Europe Tissue Plasminogen Activator Market Share by Application in 2019
Figure 57. Asia Pacific Tissue Plasminogen Activator Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Tissue Plasminogen Activator Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Tissue Plasminogen Activator Sales Market Share by Region in 2019
Figure 60. Asia Pacific Tissue Plasminogen Activator Revenue Market Share by Region in 2019
Figure 61. China Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 62. China Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 68. India Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Tissue Plasminogen Activator Market Share by Type in 2019
Figure 84. Asia Pacific Tissue Plasminogen Activator Market Share by Application in 2019
Figure 85. Latin America Tissue Plasminogen Activator Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Tissue Plasminogen Activator Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Tissue Plasminogen Activator Sales Market Share by Country in 2019
Figure 88. Latin America Tissue Plasminogen Activator Revenue Market Share by Country in 2019
Figure 89. Mexico Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Tissue Plasminogen Activator Market Share by Type in 2019
Figure 96. Latin America Tissue Plasminogen Activator Market Share by Application in 2019
Figure 97. Middle East and Africa Tissue Plasminogen Activator Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Tissue Plasminogen Activator Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Tissue Plasminogen Activator Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Tissue Plasminogen Activator Revenue Market Share by Country in 2019
Figure 101. Turkey Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Tissue Plasminogen Activator Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Tissue Plasminogen Activator Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Tissue Plasminogen Activator Market Share by Type in 2019
Figure 108. Middle East and Africa Tissue Plasminogen Activator Market Share by Application in 2019
Figure 109. North America Tissue Plasminogen Activator Sales Growth Rate Forecast (2021-2026) (MT)
Figure 110. North America Tissue Plasminogen Activator Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Tissue Plasminogen Activator Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. Europe Tissue Plasminogen Activator Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Tissue Plasminogen Activator Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Asia Pacific Tissue Plasminogen Activator Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Tissue Plasminogen Activator Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Latin America Tissue Plasminogen Activator Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Tissue Plasminogen Activator Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Middle East and Africa Tissue Plasminogen Activator Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年） Market Analysis and Insights: Global Plasminogen Activator Inhibitor 1 Market The global Plasminogen Activator Inhibitor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Plasminogen Activator Inhibitor 1 Scope and Mar…- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 転写トランス活性化因子の世界市場（～2026年） Market Analysis and Insights: Global Trans Activator Of Transcription Market The global Trans Activator Of Transcription market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Trans Activator Of Transcription Scope and Market…
- 植物活性剤の世界市場（～2026年） Plant activators are chemicals that induce plant defense responses to a broad spectrum of pathogens. Europe accounted for the largest market share for plant activators in 2017. Owing to the decreasing agricultural land in Europe, optimization of available arable land has gained increasing importance…
- 組織切除の世界市場（～2026年） Tissue ablation is the process of destruction of diseased tissues to prevent disease proliferation. Tissue ablation uses radiofrequency electric current, microwaves, laser, and ultrasound to destroy diseased tissues, which is why it becomes a preferred choice of treatment owing to its minimally inva…